Results 241 to 250 of about 492,436 (341)

ACUTE FLACCID PARALYSIS SURVEILLANCE SYSTEM: CURRENT STATUS IN AZAD JAMMU & KASHMIR- 2018

open access: diamond, 2019
Syed Nadeem-ur-Rehman   +3 more
openalex   +2 more sources

Voice and Speech in Atypical Parkinsonian Disorders

open access: yesMovement Disorders Clinical Practice, EarlyView.
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel   +48 more
wiley   +1 more source

A Question of Trust: Dynamics of the Perceived Uncertainty–Trust Dilemma With Artificial Intelligence in Strategy Process Initiation

open access: yesManagerial and Decision Economics, EarlyView.
ABSTRACT Strategists who must identify issues in uncertain environments while being cognitively constrained can increasingly rely on artificial intelligence to manage uncertainty. The potential for AI to be incorporated into strategy processes has led to a debate about the evolving collaborative relationship between strategists and AI.
Thomas Hutzschenreuter   +2 more
wiley   +1 more source

Management of Facial Paralysis Following Skull Base Surgery: A Comprehensive Narrative Review. [PDF]

open access: yesAudiol Res
De Luca LM   +10 more
europepmc   +1 more source

Efficacy of Retigabine in Treating Weakness in a Mouse Model of Hypokalemic Periodic Paralysis

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Hypokalemic periodic paralysis (HypoKPP) is an ion channelopathy causing episodic skeletal muscle weakness triggered by hypokalemia. Reduced inward rectifier K+ (Kir) channel activity contributes to membrane depolarization and paralysis, suggesting that pharmacologic activation of muscle K+ channels may restore excitability ...
Kirsten Denman, Mark M. Rich
wiley   +1 more source

Efficacy of a K+ Channel Agonist, XEN1101, For Preserving Contractility in Mouse Models of Hypokalemic Periodic Paralysis

open access: yesMuscle &Nerve, EarlyView.
Pretreatment with an agonist of Kv7 potassium channels (XEN1101) protects the soleus muscle from a loss of force during a 2 mM K+ challenge, in a mouse model of hypokalemic periodic paralysis. ABSTRACT Introduction/Aims Effective management remains lacking for recurrent episodes of acute weakness in hypokalemic periodic paralysis (HypoPP).
Viktor Chanchykov   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy